USRE35233E
Method of treating catabolic dysfunction
Abstract
The invention relates to a method of treating a catabolic dysfunction in an animal, which comprises administering to an animal a therapeutically effective amount of glutamine, or an analog thereof.
Term
Term ended
Expired 10 January 2014, 12.7 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US6245803B1 | Cited by | United States of America | Applicant |
| US6475514B1 | Cited by | United States of America | Search report |
| US2004081708A1 | Cited by | United States of America | Pre-grant |
| US2003099722A1 | Cited by | United States of America | Pre-grant |
| US5922766A | Cited by | United States of America | Search report |
| EP0059694A1 | Cites | European Patent Office (EPO) | Search report |
| EP0087750A2 | Cites | European Patent Office (EPO) | Search report |
| CA1285491A | Cites | Canada | Search report |
| US1909591A | Cites | United States of America | Search report |
| US2283817A | Cites | United States of America | Search report |
| US2662046A | Cites | United States of America | Search report |
| US2868693A | Cites | United States of America | Search report |
| US3195778A | Cites | United States of America | Search report |
| DE3206784A1 | Cites | Germany | Search report |
| US3217711A | Cites | United States of America | Search report |
| US3574857A | Cites | United States of America | Search report |
| US3701666A | Cites | United States of America | Search report |
| US3793450A | Cites | United States of America | Search report |
| US3832465A | Cites | United States of America | Search report |
| US3920838A | Cites | United States of America | Search report |
| US3950529A | Cites | United States of America | Search report |
| US3982534A | Cites | United States of America | Search report |
| US3988466A | Cites | United States of America | Search report |
| US4200095A | Cites | United States of America | Search report |
| US4265240A | Cites | United States of America | Search report |
| US4334535A | Cites | United States of America | Search report |
| US4396383A | Cites | United States of America | Search report |
| US4857555A | Cites | United States of America | Search report |
| JPS5927822A | Cites | Japan | Search report |
68 members in 18 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 77521485 | United States of America | A | |
| 90653086 | United States of America | A | |
| 26164988 | United States of America | A | |
| 85128292 | United States of America | A | |
| 18078094 | United States of America | A | |
| 261649 | – | – | – |
| 775214 | – | – | – |
| 851282 | – | – | – |
| 906530 | – | – | – |
| US19850775214 | – | – | – |
| US19860906530 | – | – | – |
| US19880261649 | – | – | – |
| US19920851282 | – | – | – |
| US19940180780 | – | – | – |
Members68
| Document | Office | Kind | |
|---|---|---|---|
| WO8701589A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6337886A | Australia | A | |
| NO871935D0 | Norway | D0 | |
| DK241287D0 | Denmark | D0 | |
| NO871935L | Norway | L | |
| DK241287A | Denmark | A | |
| EP0238553A1 | European Patent Office (EPO) | A1 | |
| JPS63501214A | Japan | A | |
| US4857555A | United States of America | A | |
| US4864896A | United States of America | A | |
| EP0238553A4 | European Patent Office (EPO) | A4 | |
| AU599335B2 | Australia | B2 | |
| CA2057055A1 | Canada | A1 | |
| EP0401056A2 | European Patent Office (EPO) | A2 | |
| WO9014823A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5827190A | Australia | A | |
| PT94223A | Portugal | A | |
| IL94549A0 | Israel | A0 | |
| IL94549D0 | Israel | D0 | |
| ZA904151B | South Africa | B | |
| CA1285491C | Canada | C | |
| US5039704A | United States of America | A | |
| US5040436A | United States of America | A | |
| EP0401056A3 | European Patent Office (EPO) | A3 | |
| FI915677A0 | Finland | A0 | |
| NO914730D0 | Norway | D0 | |
| KR920700629A | Republic of Korea | A | |
| US5040436B1 | United States of America | B1 | |
| US4864896B1 | United States of America | B1 | |
| HUT61193A | Hungary | A | |
| JPH05500655A | Japan | A | |
| AU641403B2 | Australia | B2 | |
| US5397803A | United States of America | A | |
| JPH0794389B2 | Japan | B2 | |
| USRE35233EThis record | United States of America | E | |
| IL94549A | Israel | A | |
| US5607975A | United States of America | A | |
| PT94223B | Portugal | B | |
| EP0238553B1 | European Patent Office (EPO) | B1 | |
| AT152621T | Austria | T | |
| ATE152621T1 | Austria | T1 | |
| DE3650620D1 | Germany | D1 | |
| DE3650620T2 | Germany | T2 | |
| US5684045A | United States of America | A | |
| EP0401056B1 | European Patent Office (EPO) | B1 | |
| AT160089T | Austria | T | |
| ATE160089T1 | Austria | T1 | |
| DE69031694D1 | Germany | D1 | |
| DE69031694T2 | Germany | T2 | |
| ES2111529T3 | Spain | T3 | |
| GR3025678T3 | Greece | T3 | |
| US5763485A | United States of America | A | |
| DK0401056T3 | Denmark | T3 | |
| KR0178799B1 | Republic of Korea | B1 | |
| JP2000186034A | Japan | A | |
| JP2000186035A | Japan | A | |
| JP2000198733A | Japan | A | |
| JP3068644B2 | Japan | B2 | |
| JP3113876B2 | Japan | B2 | |
| JP3113877B2 | Japan | B2 | |
| JP3113878B2 | Japan | B2 | |
| HU220214B | Hungary | B | |
| CA2057055C | Canada | C | |
| DK175711B1 | Denmark | B1 | |
| EP0401056B2 | European Patent Office (EPO) | B2 | |
| DK0401056T4 | Denmark | T4 | |
| DE69031694T3 | Germany | T3 | |
| ES2111529T5 | Spain | T5 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Fee paymentFPAY | FPAY | |
| Fee paymentFPAY | FPAY |
Numbers
- Publication, DOCDB
- RE35233
- Publication, EPODOC
- USRE35233E
- Application
- 180780
- Application, DOCDB
- 18078094
- Application, EPODOC
- US19940180780
Titles
- English
- Method of treating catabolic dysfunction
Classification
- CPC, 1
- A61K31/195
- IPC, 1
- A61K31 195
- USPC, 1
- 514563000